Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, January 2004, p. 29-34, Vol. 11, No. 1
1071-412X/04/$08.00+0 DOI: 10.1128/CDLI.11.1.29-34.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Center for International Health, University of Bergen,1 Department of Microbiology and Immunology,3 Department of Internal Medicine, Haukeland University Hospital, Bergen, Norway,4 Centers for Disease Control and Prevention (CDC)Uganda, Global AIDS Program, National Center for HIV, STD and TB, CDC, and Uganda Virus Research Institute, Entebbe, Uganda2
Received 12 August 2003/ Returned for modification 1 October 2003/ Accepted 10 October 2003
To assess the validity of the reference values for hematologic and immunologic indices currently used in Africa, we evaluated blood samples from 3,311 human immunodeficiency virus (HIV)-negative Ugandans aged 1 week to 92 years. Erythrocyte, hemoglobin, and hematocrit levels and mean corpuscular volume all significantly increased with age (P < 0.001) and were independent of gender until the age of 13 years, after which the levels were higher in males than in females (P < 0.001). White blood cell, neutrophil, lymphocyte, basophil, and monocyte counts significantly declined with age until the age of 13 years (P < 0.001), with no differences by gender, while platelet counts declined with age (P < 0.001) and showed differences by gender only among adults older than age 24 years. CD4+- and CD8+-cell counts declined with age until the age of 18 years; thereafter, females had higher counts than males. The absolute values for many of these parameters differed from those reported for populations outside Africa, suggesting that it may be necessary to develop tables of reference values for hematologic and immunologic indices specific for the African population. This may be particularly important with regard to CD4+-cell counts among children because significant differences in absolute and percent CD4+-cell counts exist between the values for Western populations and the values for the population evaluated in our study. These differences could influence the decision to initiate antiretroviral therapy among children infected with HIV.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |